cervical spondylotic radiculopathy
Conditions
Interventions
Experimental group:Basic Treatment+Supine Flexion Traction
Control group:Basic Treatment+Diclofenac Sodium Sustained Release Capsules
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. No gender limit, aged 30~75 years; 2. Meet the diagnostic criteria of cervical spondylotic radiculopathy; 3. The average Numeric Rating ScalNRS score of upper extremity pain in the past 24 hours was >3; 4. Understand and voluntarily sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Combined with congenital spinal lesions, such as lateral changes, malformations, etc., previous history of spinal trauma and spinal cord injury; 2. Combined with bone and joint tuberculosis, osteomyelitis and severe senile osteoporosis and other serious orthopedic diseases; 3. Complicated with neck and shoulder myofasciitis, perishoulder inflammation, thoracic outlet syndrome, progressive muscular atrophy, ulnar neuritis, external humerus epicondylitis, carpal tunnel syndrome, angina pectoris and other diseases that may cause pain and numbness in the neck, shoulder and (or) upper limb; 4. Patients with severe primary diseases of liver, kidney, hematopoietic system, severe liver and kidney function impairment (alanine aminotransferase ALT, aspartate aminotransferase AST or total bilirubin TBL>1.5 times the upper limit of normal reference value, or creatinine Cr> the upper limit of normal reference value), tumor patients, and patients with severe neuroendocrine system diseases; 5. Patients with a history of cervical spine surgery or planned to undergo surgery during the trial; 6. Disabled persons who cannot participate in clinical trials (blind, deaf, mute, intellectual disability, mental disorder, etc.); 7. Patients who are pregnant or planning to become pregnant and breastfeeding; 8. Patients planning to participate in other clinical trials within or near 3 months or during the study period: 9. The investigator considers it inappropriate to participate in clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Upper Limb Numeric Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Neck Numeric Rating Scale;Neck Disability Index;Neck and upper limb change score based on the global rating of change scale;Cervical range of motion ;Deep neck flexor endurance test; | — |
Countries
China
Contacts
Public ContactChen Shudong
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed